Law360, New York (January 11, 2011, 1:06 PM ET) -- The scope and use of the federal health care program exclusion authority continues to evolve. Over the past few weeks, a federal district court upheld the exclusion of three former pharmaceutical industry executives based on their responsible corporate officer doctrine convictions. The U.S. Department of Health and Human Services Office of the Inspector General (OIG) announced another unprecedented exclusion, this time against a former pharmaceutical company shareholder.
Congress repealed a mandate that state Medicaid programs exclude a wide swath of individuals and entities based on affiliations...
Sobering Developments In Health Care Exclusion
To view the full article, take a free trial now.
